| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/19/2002 | US20020132768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132767 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132340 Cell culture for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132337 Processes for preparation of marek's disease virus using continuous avian cell lines |
| 09/19/2002 | US20020132334 Nucleotide sequences coding preferential polypeptide for use in the treatment of tumors and nervous system disorders |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132329 ELL2, a new member of an ELL family of RNA polymerase II elongation factors |
| 09/19/2002 | US20020132327 Method for identifying proteases, protease target sites and regulators of protease activity in cells |
| 09/19/2002 | US20020132318 Preferential polypeptide for use as tools in the diagnosis, classification and treatment of tumors |
| 09/19/2002 | US20020132317 Polypeptide for use in the treatment and diagnosis of cancer, diabetes, hematopoeitic and nervous system disorders |
| 09/19/2002 | US20020132306 Premature antihemopliic factor; for use in the treatment of blood disorders |
| 09/19/2002 | US20020132305 Nucleotide sequences coding polypeptide for use in the treatment of rheumatoid arthritis, autoimmune, allergies, inflammation, infections, leukemia, tumors, fibrosis, psoriasis and sepsis |
| 09/19/2002 | US20020132304 Nucleotide sequences coding preferential protein for use in the treatment and diagnosis of digestive, nonimmune defense, endocrine or immune system disorders |
| 09/19/2002 | US20020132303 Nucleotide sequences coding transport protein for use in the treatment of nervous system, cardiovascular, cellular proliferative and/or differentiative, immune, inflammatory, hematopoietic, pain or metabolic disorders |
| 09/19/2002 | US20020132302 TMOF receptor and uses thereof |
| 09/19/2002 | US20020132301 Nucleotide sequences coding transport protein for use in the treatment of vision defcets, liver, cardiovascular, nervous system and cell proliferation disorders |
| 09/19/2002 | US20020132299 Production of proteins by cell culture |
| 09/19/2002 | US20020132298 Nucleotide sequences coding polypeptide for use in the treatment of muscular and nervous sytem disosrders |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132293 Mammalian neuralized family transcriptional regulators and uses therefor |
| 09/19/2002 | US20020132292 Peptide for use in treatment of gastrointestinal, muscle and respiratory disorders |
| 09/19/2002 | US20020132291 Polypeptide for use in human therapeutics and diagnostics; for use in treating tumors |
| 09/19/2002 | US20020132290 Coordinate cytokine regulatory sequences |
| 09/19/2002 | US20020132289 Olfactory receptors and their utilizations |
| 09/19/2002 | US20020132278 Measuring level of pregnancy- associated plasma protein-A (PAPP-A) in biological sample from a non-pregnant patient; comparing level with that of control subjects; diagnosing inflammatory condition based on level of PAPP-Acontrol |
| 09/19/2002 | US20020132271 Reagents, method and kit for detecting phosphinothricin-N-acetyltransferase protein |
| 09/19/2002 | US20020132269 For use in diagnosis therapy |
| 09/19/2002 | US20020132268 Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers |
| 09/19/2002 | US20020132262 Nucleotide sequences coding tumor suppressor protein for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132255 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of breast cancer |
| 09/19/2002 | US20020132253 Nucleotide sequences coding membrane protein for use in diagnosis and treatment of athersclerosis, infections, arthritis, cancer, kidney and nervous system disorders |
| 09/19/2002 | US20020132252 Nucleotide sequences coding membrane protein for use in the diagnosis and treatment of infections, arthritis, nervous system and kidney disorders, cancer and atherosclerosis |
| 09/19/2002 | US20020132250 EGF motif protein, EGFL6 materials and methods |
| 09/19/2002 | US20020132240 Nucleotide sequences coding membrane proteins for use in treatment of cancer, infections, cardiavascular, nervous system, skin and kidney disorders |
| 09/19/2002 | US20020132238 Progesterone receptor complex p23-like protein |
| 09/19/2002 | US20020132229 Detecting modulators of viral propagation; obtain cell, transform with expression vector containing modulator, incubate cell with virus, recover propagating cells |
| 09/19/2002 | US20020132223 Methods for modulating activity of the FXR nuclear receptor |
| 09/19/2002 | US20020132017 Composition and method for preserving progenitor cells |
| 09/19/2002 | US20020132016 Extracting a fraction with an optical absorbance of 210-250 nm; inhibiting the growth of endothelial cells and vascularization; anticancer agents |
| 09/19/2002 | US20020131984 Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide |
| 09/19/2002 | US20020131983 Method for inducing an immunological response in a host by administering to the host at least one antigen and a lipoprotein |
| 09/19/2002 | US20020131981 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 09/19/2002 | US20020131976 Tuberculosis vaccine |
| 09/19/2002 | US20020131975 Abundant extracellular products and methods for their production and use |
| 09/19/2002 | US20020131971 Compositions and methods for the therapy and diagnosis of colon cancer |
| 09/19/2002 | US20020131970 Fibrinogen homolog capable of binding to endothelial cells in an arginine-glycine-aspartic acid (RGD)-independent manner that inhibits fibrinogen binding to endothelial cells; inhibiting tumor metastasis |
| 09/19/2002 | US20020131963 Methods and compositions for treating type i diabetes using glutamic acid decarboxylase |
| 09/19/2002 | US20020131961 Gene transfer of Bcl2 and a selected transgene to cells; Bcl2 protects cells which express it from apoptosis so they can be selected by administering an apoptotic agent |
| 09/19/2002 | US20020131959 Contacting an organ, tissue or cells with transforming growth factor beta 1 (TGF beta 1) |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | US20020130082 Endotoxin adsorbent, and a method of removing endotoxin by using the same |
| 09/19/2002 | DE10112748A1 Erfindung betreffend HCV-Erkrankungen Invention concerning HCV disease |
| 09/19/2002 | DE10111433A1 Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen Replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from porcine and human cells |
| 09/19/2002 | CA2702192A1 Igf antagonist peptides |
| 09/19/2002 | CA2692552A1 Novel protein isolated from pleurotus cornucopiae |
| 09/19/2002 | CA2473979A1 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | CA2470152A1 Transfection complexes comprising a novel peptide as cell surface receptor binding component |
| 09/19/2002 | CA2455413A1 Mammalian neuralized family transcriptional regulators and uses therefor |
| 09/19/2002 | CA2454959A1 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441454A1 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2441006A1 Methods and materials relating to fibulin-like polypeptides and polynucleotides |
| 09/19/2002 | CA2440974A1 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | CA2440773A1 Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules |
| 09/19/2002 | CA2440664A1 Phycoerythrin labeled thyronine analogues and assays using the labeled analogues |
| 09/19/2002 | CA2440658A1 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2440593A1 Compositions and methods comprising west nile virus polypeptides |
| 09/19/2002 | CA2440563A1 Novel human egf-family proteins and polynucleotides encoding the same |
| 09/19/2002 | CA2440561A1 Synthetic molecular spring device |
| 09/19/2002 | CA2440443A1 Computer-based strategy for peptide and protein conformational ensemble enumeration and ligand affinity analysis |
| 09/19/2002 | CA2440433A1 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | CA2440345A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/19/2002 | CA2440337A1 Novel proteins and nucleic acids encoding same |
| 09/19/2002 | CA2440330A1 Lipid metabolism regulators in plants |
| 09/19/2002 | CA2440221A1 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | CA2440058A1 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27 |
| 09/19/2002 | CA2439956A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/19/2002 | CA2439932A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | CA2439750A1 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation |
| 09/19/2002 | CA2439735A1 Igf antagonist peptides |
| 09/19/2002 | CA2439702A1 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof |
| 09/19/2002 | CA2439653A1 Remedies for arthritis deformans and remedies for rheumatoid arthritis |
| 09/19/2002 | CA2439637A1 Human serpin polypeptides |
| 09/19/2002 | CA2439498A1 Somatostatin antagonists |
| 09/19/2002 | CA2439254A1 Life attenuated strains of prrs virus |
| 09/19/2002 | CA2439236A1 Immuno-enhancing agent |
| 09/19/2002 | CA2439188A1 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | CA2438385A1 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | CA2438074A1 Process for production of polypeptides |
| 09/19/2002 | CA2437960A1 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/19/2002 | CA2437756A1 Nucleic acid-associated proteins |
| 09/19/2002 | CA2435998A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | CA2434762A1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/18/2002 | EP1241598A1 Method and device for calculating optimization solution of multiple mutant protein amino acid sequence, and storage medium where program for executing the method is stored |
| 09/18/2002 | EP1241477A1 Diagnosis and treatment of enterococcus faecium related disease |
| 09/18/2002 | EP1241281A1 Tin plating |